Steinman_1990_FASEB.J_4_2726

Reference

Title : Prospects for specific immunotherapy in myasthenia gravis - Steinman_1990_FASEB.J_4_2726
Author(s) : Steinman L , Mantegazza R
Ref : FASEB Journal , 4 :2726 , 1990
Abstract :

Myasthenia gravis is an autoimmune disease resulting from a breakdown in T and B cell tolerance to acetylcholine receptor (AChR). Autoantibodies to AChR mediate the disease. Recent advances in experimental immunotherapy of autoimmune disease provide several possibilities for specific intervention in this well-characterized condition.

PubMedSearch : Steinman_1990_FASEB.J_4_2726
PubMedID: 2197152

Related information

Citations formats

Steinman L, Mantegazza R (1990)
Prospects for specific immunotherapy in myasthenia gravis
FASEB Journal 4 :2726

Steinman L, Mantegazza R (1990)
FASEB Journal 4 :2726